Formoterol: Phase I/II started

Meridica started a 2-way, crossover U.K. Phase I/II trial comparing its inhaled formoterol to Foradil in 28 patients. Novartis AG (NVS; SWX:NOVN, Basel, Switzerland) markets Foradil inhaled formotero...